NK Cells Mediate Costimulation Blockade-Resistant Rejection of Allogeneic Stem Cells During Nonmyeloablative Transplantation
Open Access
- 24 November 2005
- journal article
- Published by Elsevier in American Journal of Transplantation
- Vol. 6 (2), 292-304
- https://doi.org/10.1111/j.1600-6143.2005.01172.x
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Extended efalizumab therapy improves chronic plaque psoriasis: Results from a randomized phase III trialJournal of the American Academy of Dermatology, 2005
- Current concepts and review of efalizumab in the treatment of psoriasisDermatologic Clinics, 2004
- LFA-1 signaling through p44/42 is coupled to perforin degranulation in CD56+CD8+ natural killer cellsBlood, 2004
- Loss or mismatch of MHC class I is sufficient to trigger NK cell‐mediated rejection of resting lymphocytes in vivo – role of KARAP/DAP12‐dependent and ‐independent pathwaysEuropean Journal of Immunology, 2004
- Blood Lymphocytes, Monocytes and NK Cells Modulate Their Expression of CD44, ICAM‐1, LFA‐1 and MHC Class II After Arrival Into Lymphoid OrgansImmunological Investigations, 2004
- Modulation of Ly49D Expression after Allogeneic Bone Marrow Transplantation and Functional ConsequencesImmunobiology, 2002
- Anti-lymphocyte function-associated antigen-1 monoclonal antibody inhibits CD40 ligand-independent immune responses and prevents chronic vasculopathy in CD40 ligand-deficient mice1Transplantation, 2002
- Stem cells: A minireviewJournal of Cellular Biochemistry, 2002
- Anti-adhesion antibodiesTransplant Immunology, 2002
- Acute rejection of murine bone marrow allografts by natural killer cells and T cells. Differences in kinetics and target antigens recognized.The Journal of Experimental Medicine, 1987